Project number | 0206-17-ГК |
Project title | Production of industrial anti-rabies cultural vaccine “Rhabdovak” for animals according to GMP standards |
Applicant | LLP “Scientific and production enterprise “Antigen” |
Grant Recipient | LLP “Scientific and production enterprise “Antigen” |
Private partner | No |
Implementation period | 2017-2021 years |
Location of implementation (city/region) | Alma-Ata’s region |
Sector | healthcare |
Project objective | To organize the industrial production of the anti-rabies cultural vaccine “Rhabdovac” against animal rabies according to the GMP standard. |
Project description | Development and organization of production according to the GMP standard of a cultural vaccine for animal rabies. The project has developed new technologies in the field of veterinary medicine and biotechnology, namely the creation of the production of a competitive drug – a purified concentrated cultural vaccine for injectable use against rabies in domestic animals. The creation of high-tech production will allow providing a biological product according to international standards, to train qualified specialists, to carry out import substitution. |
Site | https://antigen.kz |
List of products sold and their price | Rabies cultural vaccine “Rhabdovak” for animals – 76 тенге |
Project team (names) | 1. Akhmetsadykov Nurlan Nuroldinovich; 2. Khusainov Damir Mikdatovich; 3. Batanova Zhanat Mukhametkalievna; 4. Shanbaev Bakdaulet Unerbekovich; 5 Kulmanbetov Kuat Datembaevich; 6. Imanbekova Tolganai Abdikerimovna |
Indicators | sales – 104 848 072,10 тенге; export – 13 954 710 тенге; taxes – 28 577 199 тенге; number of workplaces – 12. |